简体中文|English
检索试验 按国家、省（市）统计 按疾病代码统计 按试验实施单位统计 按试验主办单位统计 按经费或物资来源统计 按征募研究对象情况统计 按注册状态统计 按干预措施统计 按伦理委员会统计 按研究类型统计
Impact of COVID-19 on Laboratory Professionals-Early Evidences from a Survey at a Clinical Chemistry Laboratory in a Developing Country
下载XML文档

注册号：

Registration number：

 ChiCTR2000033899 

最近更新日期：

Date of Last Refreshed on：

 2020-06-16 07:40:26 

注册时间：

Date of Registration：

 2020-06-16 00:00:00 

注册号状态：

预注册

Registration Status：

Prospective registration

注册题目：

Impact of COVID-19 on Laboratory Professionals-Early Evidences from a Survey at a Clinical Chemistry Laboratory in a Developing Country

Public title：

Impact of COVID-19 on Laboratory Professionals-Early Evidences from a Survey at a Clinical Chemistry Laboratory in a Developing Country

注册题目简写：

English Acronym：

研究课题的正式科学名称：

Impact of COVID-19 on Laboratory Professionals-Early Evidences from a Survey at a Clinical Chemistry Laboratory in a Developing Country

Scientific title：

Impact of COVID-19 on Laboratory Professionals-Early Evidences from a Survey at a Clinical Chemistry Laboratory in a Developing Country

研究课题代号(代码)：

Study subject ID：

在二级注册机构或其它机构的注册号：

The registration number of the Partner Registry or other register：

申请注册联系人：

Sibtain Ahmed 

研究负责人：

Sibtain Ahmed 

Applicant：

Sibtain Ahmed 

Study leader：

Sibtain Ahmed 

申请注册联系人电话：

Applicant telephone：

 +92 33 32707952

研究负责人电话：

Study leader's
telephone：

+92 21 34861927

申请注册联系人传真 ：

Applicant Fax：

研究负责人传真：

Study leader's fax：

申请注册联系人电子邮件：

Applicant E-mail：

 sibtain.ahmed@aku.edu

研究负责人电子邮件：

Study leader's E-mail：

 sibtain.ahmed@aku.edu

申请单位网址(自愿提供)：

Applicant website(voluntary supply)：

研究负责人网址(自愿提供)：

Study leader's website(voluntary supply)：

申请注册联系人通讯地址：

Aga Khan University, Stadium Road, Karachi, Pakistan

研究负责人通讯地址：

Aga Khan University, Stadium Road, Karachi, Pakistan

Applicant address：

Aga Khan University, Stadium Road, Karachi, Pakistan

Study leader's address：

Aga Khan University, Stadium Road, Karachi, Pakistan

申请注册联系人邮政编码：

Applicant postcode：

 74800

研究负责人邮政编码：

Study leader's postcode：

 74800

申请人所在单位：

巴基斯坦卡拉齐阿迦汗大学

Applicant's institution：

Clinical Chemistry, Aga Khan University

研究负责人所在单位：

巴基斯坦卡拉齐阿迦汗大学

Affiliation of the Leader：

Clinical Chemistry, Aga Khan University

是否获伦理委员会批准：

是

Approved by ethic committee：

Yes

伦理委员会批件文号：

Approved No. of ethic committee：

 2020-4861-10674.

伦理委员会批件附件：

Approved file of Ethical Committee：

批准本研究的伦理委员会名称：

Ethics Review Committee, Aga Khan University Karachi

Name of the ethic committee：

Ethics Review Committee, Aga Khan University Karachi

伦理委员会批准日期：

Date of approved by ethic committee：

 2020-06-04 00:00:00

伦理委员会联系人：

Ethics Review Committee, Aga Khan University Karachi

Contact Name of the ethic committee：

Ethics Review Committee, Aga Khan University Karachi

伦理委员会联系地址：

Ethics Review Committee, Aga Khan University, Stadium Road, Karachi, Pakistan

Contact Address of the ethic committee：

Ethics Review Committee, Aga Khan University, Stadium Road, Karachi, Pakistan

伦理委员会联系人电话：

Contact phone of the ethic committee：

伦理委员会联系人邮箱：

Contact email of the ethic committee：

研究实施负责（组长）单位：

None

Primary sponsor：

None

研究实施负责（组长）单位地址：

None

Primary sponsor's address：

None

试验主办单位(项目批准或申办者)：

Secondary sponsor：

经费或物资来源：

None

Source(s) of funding：

None

研究疾病：

新型冠状病毒肺炎(COVID-19)  

Target disease：

Novel Coronavirus Pneumonia (COVID-19)

研究疾病代码：

Target disease code：

研究类型：

卫生服务研究

Study type：

Health Services Research

研究所处阶段：

 其它 

Study phase：

N/A

研究设计：

连续入组 

Study design：

Sequential 

研究目的：

The aim of this survey is to analyze the lab professionals’ perspectives, in terms of the challenges, financial implications, fears, motivation and satisfaction from organizational processes and policies adopted, amid the COVID-19 crisis.  

Objectives of Study：

The aim of this survey is to analyze the lab professionals perspectives, in terms of the challenges, financial implications, fears, motivation and satisfaction from organizational processes and policies adopted, amid the COVID-19 crisis.

药物成份或治疗方案详述：

This cross-sectional survey will be conducted at the section of Clinical Chemistry, department of Pathology and Laboratory Medicine, the Aga Khan University, Karachi after exemption from ethical review committee over a period of one month. An e-questionnaire would be developed using google docs and administered online via email link to all the fulltime lab professionals including technologists, managers, residents and faculty serving at the section of Clinical Chemistry. Electronic consent for participation will be acquired at the initial page of the survey. The participation in the survey will be completely voluntarily and any person can opt out and withdraw by not submitting the answers. To ensure confidentiality any personal detail that might lead to identification of the personnel will not be acquired as part of the survey. Additionally, all data will be stored in a password protected electronic format.  

Description for medicine or protocol of treatment in detail：

This cross-sectional survey will be conducted at the section of Clinical Chemistry, department of Pathology and Laboratory Medicine, the Aga Khan University, Karachi after exemption from ethical review committee over a period of one month. An e-questionnaire would be developed using google docs and administered online via email link to all the fulltime lab professionals including technologists, managers, residents and faculty serving at the section of Clinical Chemistry. Electronic consent for participation will be acquired at the initial page of the survey. The participation in the survey will be completely voluntarily and any person can opt out and withdraw by not submitting the answers. To ensure confidentiality any personal detail that might lead to identification of the personnel will not be acquired as part of the survey. Additionally, all data will be stored in a password protected electronic format.  

纳入标准：

Inclusion criteria

排除标准：

Admin Staff, support staff, housekeeping staff and trainee technologists.

Exclusion criteria：

Admin Staff, support staff, housekeeping staff and trainee technologists.

研究实施时间：

Study execute time：

从 From 2020-06-04 00:00:00至 To 2020-06-14 00:00:00  

征募观察对象时间：

Recruiting time：

从 From 2020-06-04 00:00:00 至 To 2020-06-14 00:00:00

干预措施：

Interventions：

组别：

Laboratory staff

样本量：

 64

Group：

Laboratory staff

Sample size：

干预措施：

Survey

干预措施代码：

Intervention：

Survey

Intervention code：

研究实施地点：

Countries of recruitment and research settings：

国家：

 巴基斯坦

省(直辖市)：

 信德 

市(区县)：

 卡拉奇 

Country：

Pakistan

Province：

Sind

City：

Karachi

单位(医院)：

 Pakistan 

单位级别：

 三级医院 

Institution
hospital：

Clinical Chemistry, Aga Khan University

Level of the institution：

Tertiary Hospital

测量指标：

Outcomes：

指标中文名：

Survey responses

指标类型：

主要指标

Outcome：

Survey responses

Type：

Primary indicator

测量时间点：

测量方法：

Measure time point of outcome：

Measure method：

采集人体标本：

Collecting sample(s)
from participants：

标本中文名：

None

组织：

None

Sample Name：

None

Tissue：

None

人体标本去向

 使用后销毁  

说明

Fate of sample：

Destruction after use  

Note：

征募研究对象情况：

Recruiting status：

结束

/Completed

年龄范围：

Participant age：
最小 Min age 20 岁 years
最大 Max age 65 岁 years

性别：

男女均可

Gender：

Both

随机方法（请说明由何人用什么方法产生随机序列）：

N/A

Randomization Procedure (please state who generates the random number sequence and by what method)：

N/A

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法：

N/A

Blinding：

N/A

试验完成后的统计结果（上传文件）：

Calculated Results after
the Study Completed(upload file)：

是否共享原始数据：

IPD sharing

否No

共享原始数据的方式（说明：请填入公开原始数据日期和方式，如采用网络平台，需填该网络平台名称和网址）：

None

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url)：

None

数据采集和管理（说明：数据采集和管理由两部分组成，一为病例记录表(Case Record Form, CRF)，二为电子采集和管理系统(Electronic Data Capture, EDC)，如ResMan即为一种基于互联网的EDC：

None

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture：

None

数据与安全监察委员会：

Data and Safety Monitoring Committee：

无/No

注册人：

Name of Registration：

  2020-06-16 07:40:26
返回列表
欢迎访问WHO国际临床试验注册平台 Clinical Trials Hong Kong

中国临床试验注册中心 - 世界卫生组织国际临床试验注册平台一级注册机构

Copyright(c) (2005 - 2023) Chictr.org.cn.All rights reserved. 中国临床试验注册中心 版权所有

蜀ICP备16010396号-9

提示：推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统